These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 16029370)

  • 1. T1796A BRAF mutation is absent in Merkel cell carcinoma.
    Worda M; Sreevidya CS; Ananthaswamy HN; Cerroni L; Kerl H; Wolf P
    Br J Dermatol; 2005 Jul; 153(1):229-32. PubMed ID: 16029370
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma.
    Krasagakis K; Metaxari M; Zervou M; Stathopoulos EN; Eberle J; Kanitakis J; Georgoulias V; Krüger-Krasagakis S; Tavernarakis N; Tosca AD
    Anticancer Res; 2011 Mar; 31(3):807-11. PubMed ID: 21498700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma.
    Davids MS; Charlton A; Ng SS; Chong ML; Laubscher K; Dar M; Hodge J; Soong R; Goh BC
    J Clin Oncol; 2009 Sep; 27(26):e97-100. PubMed ID: 19564526
    [No Abstract]   [Full Text] [Related]  

  • 4. Merkel cell carcinoma: insights into pathogenesis.
    Heymann WR
    J Am Acad Dermatol; 2008 Sep; 59(3):503-4. PubMed ID: 18694681
    [No Abstract]   [Full Text] [Related]  

  • 5. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
    Xing M
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):263-6. PubMed ID: 16117812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase (TERT) promoter mutations are infrequent in Merkel cell carcinomas.
    Chung HJ; Yang S; Succaria F; Bhawan J
    J Am Acad Dermatol; 2015 Nov; 73(5):864-5. PubMed ID: 26475538
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromosomal evolution in a Merkel cell carcinoma.
    Schlegelberger B; Bartels H; Sterry W
    Cancer Genet Cytogenet; 1994 Jul; 75(1):74-6. PubMed ID: 8039170
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinct gene expression profiles in two cases of Merkel cell polyomavirus-negative Merkel cell carcinoma: shedding light on an esoteric entity.
    Nguyen HP; Pickrell BB; Tschen JA; He Q; Rady PL; Tyring SK
    Int J Dermatol; 2015 Dec; 54(12):e549-51. PubMed ID: 26341375
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical Phacomatosis Pigmentokeratotica as the Expression of a Mosaic RASopathy With the BRAF-Glu586Lys Mutation.
    Ayala D; Ramón MD; Martín JM; Jordá E
    Actas Dermosifiliogr; 2016 May; 107(4):344-6. PubMed ID: 26703821
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic and viral findings in two different primary Merkel cell carcinomas in a 76-year-old woman.
    Dousset L; Dutriaux C; Taïeb A; Chibon F; Foulongne V; Frouin E; Jullié ML; Jouary T
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e42-e43. PubMed ID: 27027702
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of immunoglobulin heavy chain rearrangement in primary Merkel cell carcinomas.
    Gambichler T; Segert MH; Höxtermann S; Stockfleth E; Doerler M
    Clin Exp Dermatol; 2018 Dec; 43(8):947. PubMed ID: 29797735
    [No Abstract]   [Full Text] [Related]  

  • 13. [Commentary to "update on tumour biology and treatment of merkel cell carcinoma"].
    Rieger UM; Pierer G
    Handchir Mikrochir Plast Chir; 2011 Dec; 43(6):350. PubMed ID: 21287440
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytogenetic study in a bone marrow metastatic Merkel cell carcinoma.
    Smadja N; de Gramont A; Gonzalez-Canali G; Louvet C; Wattel E; Krulik M
    Cancer Genet Cytogenet; 1991 Jan; 51(1):85-7. PubMed ID: 1984852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Merkel cell carcinoma: a 50-year retrospect.
    Schwartz RA; Lambert WC
    J Surg Oncol; 2005 Jan; 89(1):5. PubMed ID: 15611999
    [No Abstract]   [Full Text] [Related]  

  • 16. BRAF mutation in neuroblastoma: A rare finding.
    Hutchins SC; Ferguson SR; Li G; Beierle EA; Alva E
    Pediatr Blood Cancer; 2023 Feb; 70(2):e29945. PubMed ID: 36069597
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic evidence of a sarcomatoid transformation in Merkel cell carcinoma.
    Barbieux S; Tallet A; Collin C; Tallegas M; Delalande F; Bens G; Levy A; Kalampokas A; Schrama D; Houben R; Touzé A; Garcia J; Macagno N; Appay R; Samimi M; Guyétant S; Kervarrec T
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e45-e48. PubMed ID: 35972820
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of mutant and wild-type p53 proteins in Merkel cell carcinoma.
    Carson HJ; Lueck NE; Horten BC
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):326. PubMed ID: 10798862
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanding the clinical spectrum of mosaic BRAF skin phenotypes.
    Sorlin A; Carmignac V; Amiel J; Boccara O; Fraitag S; Maruani A; Theiler M; Weibel L; Duffourd Y; Philippe C; Thauvin-Robinet C; Faivre L; Rivière JB; Vabres P; Kuentz P
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e690-e693. PubMed ID: 34051131
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutational analysis of merkel cell carcinoma.
    Erstad DJ; Cusack JC
    Cancers (Basel); 2014 Oct; 6(4):2116-36. PubMed ID: 25329450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.